CN114689737A - 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 - Google Patents
一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 Download PDFInfo
- Publication number
- CN114689737A CN114689737A CN202111666604.6A CN202111666604A CN114689737A CN 114689737 A CN114689737 A CN 114689737A CN 202111666604 A CN202111666604 A CN 202111666604A CN 114689737 A CN114689737 A CN 114689737A
- Authority
- CN
- China
- Prior art keywords
- solution
- impurity
- methyl ester
- sample
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 16
- 238000004458 analytical method Methods 0.000 title claims abstract description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 132
- 238000001514 detection method Methods 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000008055 phosphate buffer solution Substances 0.000 claims abstract description 7
- 238000010828 elution Methods 0.000 claims abstract description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 100
- 238000000034 method Methods 0.000 claims description 38
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 24
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 13
- 238000012856 packing Methods 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims 10
- 239000000945 filler Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 79
- 239000000523 sample Substances 0.000 description 75
- 239000013558 reference substance Substances 0.000 description 63
- 239000003085 diluting agent Substances 0.000 description 43
- 238000005303 weighing Methods 0.000 description 43
- 238000007865 diluting Methods 0.000 description 34
- 239000012071 phase Substances 0.000 description 34
- AAEQXEDPVFIFDK-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-n,3-diphenyloxirane-2-carboxamide Chemical compound C=1C=CC=CC=1NC(=O)C1(C(=O)C(C)C)OC1(C=1C=CC=CC=1)C(=O)C1=CC=C(F)C=C1 AAEQXEDPVFIFDK-UHFFFAOYSA-N 0.000 description 31
- 239000011550 stock solution Substances 0.000 description 24
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 22
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 22
- 238000012360 testing method Methods 0.000 description 17
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 14
- -1 o-chlorophenyl glycine Chemical compound 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 239000012488 sample solution Substances 0.000 description 9
- 239000012085 test solution Substances 0.000 description 9
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000012937 correction Methods 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 229940095064 tartrate Drugs 0.000 description 7
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 6
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 6
- 229960003009 clopidogrel Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 239000012490 blank solution Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011003 system suitability test Methods 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 description 2
- ROBLTDOHDSGGDT-UHFFFAOYSA-M sodium;pentane-1-sulfonate Chemical compound [Na+].CCCCCS([O-])(=O)=O ROBLTDOHDSGGDT-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- RWCJDLOXCINLFB-UHFFFAOYSA-N 2-(2-chlorophenyl)-2-oxoacetaldehyde Chemical compound ClC1=CC=CC=C1C(=O)C=O RWCJDLOXCINLFB-UHFFFAOYSA-N 0.000 description 1
- FWALJUXKWWBNEO-UHFFFAOYSA-N 2-(4-chloroanilino)acetic acid Chemical compound OC(=O)CNC1=CC=C(Cl)C=C1 FWALJUXKWWBNEO-UHFFFAOYSA-N 0.000 description 1
- ZDMWSYXPZCVAOH-UHFFFAOYSA-N C(=O)(O)C(O)C(O)C(=O)O.COC(CN)=O Chemical compound C(=O)(O)C(O)C(O)C(=O)O.COC(CN)=O ZDMWSYXPZCVAOH-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Substances ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8679—Target compound analysis, i.e. whereby a limited number of peaks is analysed
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
时间(分钟) | 流动相A(体积%) | 流动相B(体积%) |
0 | 10 | 90 |
3 | 10 | 90 |
23 | 26 | 74 |
48 | 85 | 15 |
60 | 85 | 15 |
61 | 10 | 90 |
70 | 10 | 90 |
S-邻氯苯甘氨酸甲酯酒石酸盐拖尾因子 | 杂质C与杂质D分离度 |
0.92 | 4.84 |
时间(min) | A% | B% |
0 | 10 | 90 |
3 | 10 | 90 |
23 | 26 | 74 |
48 | 85 | 15 |
60 | 85 | 15 |
61 | 10 | 90 |
70 | 10 | 90 |
时间(min) | A% | B% |
0 | 10 | 90 |
3 | 10 | 90 |
23 | 26 | 74 |
48 | 85 | 15 |
60 | 85 | 15 |
61 | 10 | 90 |
70 | 10 | 90 |
时间(min) | A% | B% |
0 | 10 | 90 |
3 | 10 | 90 |
23 | 26 | 74 |
48 | 85 | 15 |
60 | 85 | 15 |
61 | 10 | 90 |
70 | 10 | 90 |
耐用性① | 流动相pH值变为1.7,其余条件不变; |
耐用性② | 流动相pH值变为1.9,其余条件不变; |
耐用性③ | 更换同类型不同批次色谱柱,其余条件不变; |
时间(min) | A% | B% |
0 | 5 | 95 |
5 | 5 | 95 |
40 | 20 | 80 |
50 | 45 | 55 |
60 | 55 | 45 |
80 | 80 | 20 |
81 | 5 | 95 |
90 | 5 | 95 |
时间(min) | A% | B% |
0 | 10 | 90 |
3 | 10 | 90 |
23 | 26 | 74 |
48 | 85 | 15 |
60 | 85 | 15 |
61 | 10 | 90 |
70 | 10 | 90 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111666604.6A CN114689737B (zh) | 2021-12-31 | 2021-12-31 | 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111666604.6A CN114689737B (zh) | 2021-12-31 | 2021-12-31 | 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114689737A true CN114689737A (zh) | 2022-07-01 |
CN114689737B CN114689737B (zh) | 2023-12-08 |
Family
ID=82136910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111666604.6A Active CN114689737B (zh) | 2021-12-31 | 2021-12-31 | 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114689737B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115266977A (zh) * | 2022-07-25 | 2022-11-01 | 山东普洛汉兴医药有限公司 | 一种测定dl-对氯苯丝氨酸乙酯含量的hplc方法 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004108665A2 (en) * | 2003-04-24 | 2004-12-16 | Sun Pharmaceutical Industries Limited | A process for preparation of clopidogrel |
CN101497575A (zh) * | 2008-01-28 | 2009-08-05 | 上海华理生物医药有限公司 | 一种s-(+)-邻氯苯甘氨酸甲酯的拆分方法 |
CN101898975A (zh) * | 2010-07-15 | 2010-12-01 | 启东市沪东化工有限公司 | S-邻氯苯甘氨酸甲酯酒石酸盐的合成方法 |
CN101906032A (zh) * | 2010-07-14 | 2010-12-08 | 华东理工大学 | 回收和循环使用l-(+)-酒石酸的方法 |
CN103412064A (zh) * | 2013-07-25 | 2013-11-27 | 苏州立新制药有限公司 | 通过高效液相色谱检测邻氯苯甘氨酸杂质的方法 |
CN103980288A (zh) * | 2014-06-03 | 2014-08-13 | 成都医路康医学技术服务有限公司 | 一种氯吡格雷的生产工艺 |
CN107941970A (zh) * | 2017-11-08 | 2018-04-20 | 常州合全新药研发有限公司 | D‑对羟基苯甘氨酸及其对映异构体的分离检测方法 |
CN108872436A (zh) * | 2018-07-13 | 2018-11-23 | 山东汉兴医药科技有限公司 | 一种d(-)对羟基苯甘氨酸甲酯中d(-)对羟基苯甘氨酸含量的分析方法 |
CN108864036A (zh) * | 2018-08-01 | 2018-11-23 | 江苏八巨药业有限公司 | 制备D-(+)-α-(2-噻吩乙胺基)-α-(2-氯苯基)醋酸甲酯盐酸盐的方法 |
CN110940745A (zh) * | 2019-11-28 | 2020-03-31 | 河北科技大学 | S-2-氨基-2-(2-氯苯基)乙酸甲酯或其盐中有关物质的检测方法 |
CN112851631A (zh) * | 2020-12-31 | 2021-05-28 | 宣城美诺华药业有限公司 | 硫酸氢氯吡格雷中间体的杂质及其制备方法、含量控制方法 |
CN112939841A (zh) * | 2021-03-10 | 2021-06-11 | 康化(上海)新药研发有限公司 | 一种(2s)-2-n-芴甲氧羰基氨基-4-(3-氯苯基)丁酸的合成方法 |
CN113484430A (zh) * | 2021-05-28 | 2021-10-08 | 重庆医药高等专科学校 | 一种采用高效液相色谱法测定l-丙氨酸异丙酯盐酸盐有关物质的方法 |
-
2021
- 2021-12-31 CN CN202111666604.6A patent/CN114689737B/zh active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004108665A2 (en) * | 2003-04-24 | 2004-12-16 | Sun Pharmaceutical Industries Limited | A process for preparation of clopidogrel |
CN101497575A (zh) * | 2008-01-28 | 2009-08-05 | 上海华理生物医药有限公司 | 一种s-(+)-邻氯苯甘氨酸甲酯的拆分方法 |
CN101906032A (zh) * | 2010-07-14 | 2010-12-08 | 华东理工大学 | 回收和循环使用l-(+)-酒石酸的方法 |
CN101898975A (zh) * | 2010-07-15 | 2010-12-01 | 启东市沪东化工有限公司 | S-邻氯苯甘氨酸甲酯酒石酸盐的合成方法 |
CN103412064A (zh) * | 2013-07-25 | 2013-11-27 | 苏州立新制药有限公司 | 通过高效液相色谱检测邻氯苯甘氨酸杂质的方法 |
CN103980288A (zh) * | 2014-06-03 | 2014-08-13 | 成都医路康医学技术服务有限公司 | 一种氯吡格雷的生产工艺 |
CN107941970A (zh) * | 2017-11-08 | 2018-04-20 | 常州合全新药研发有限公司 | D‑对羟基苯甘氨酸及其对映异构体的分离检测方法 |
CN108872436A (zh) * | 2018-07-13 | 2018-11-23 | 山东汉兴医药科技有限公司 | 一种d(-)对羟基苯甘氨酸甲酯中d(-)对羟基苯甘氨酸含量的分析方法 |
CN108864036A (zh) * | 2018-08-01 | 2018-11-23 | 江苏八巨药业有限公司 | 制备D-(+)-α-(2-噻吩乙胺基)-α-(2-氯苯基)醋酸甲酯盐酸盐的方法 |
CN110940745A (zh) * | 2019-11-28 | 2020-03-31 | 河北科技大学 | S-2-氨基-2-(2-氯苯基)乙酸甲酯或其盐中有关物质的检测方法 |
CN112851631A (zh) * | 2020-12-31 | 2021-05-28 | 宣城美诺华药业有限公司 | 硫酸氢氯吡格雷中间体的杂质及其制备方法、含量控制方法 |
CN112939841A (zh) * | 2021-03-10 | 2021-06-11 | 康化(上海)新药研发有限公司 | 一种(2s)-2-n-芴甲氧羰基氨基-4-(3-氯苯基)丁酸的合成方法 |
CN113484430A (zh) * | 2021-05-28 | 2021-10-08 | 重庆医药高等专科学校 | 一种采用高效液相色谱法测定l-丙氨酸异丙酯盐酸盐有关物质的方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115266977A (zh) * | 2022-07-25 | 2022-11-01 | 山东普洛汉兴医药有限公司 | 一种测定dl-对氯苯丝氨酸乙酯含量的hplc方法 |
CN115266977B (zh) * | 2022-07-25 | 2024-02-27 | 山东普洛汉兴医药有限公司 | 一种测定dl-对氯苯丝氨酸乙酯含量的hplc方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114689737B (zh) | 2023-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115453012B (zh) | 一种同时测定氢溴酸伏硫西汀中多个位置异构体的反相hplc方法 | |
CN115097023A (zh) | 佐米胺有关物质的高效液相色谱检测方法 | |
CN107870209B (zh) | 测定利格列汀原料药中杂质含量的方法 | |
CN113588837B (zh) | 一种盐酸莫西沙星有关物质的检测方法 | |
CN114689737B (zh) | 一种s-邻氯苯甘氨酸甲酯酒石酸盐有关物质的分析方法 | |
CN113295805A (zh) | 一种药物中水合肼的检测方法 | |
CN116297978A (zh) | Hplc法分离测定泊沙康唑z3及其杂质与溶剂的方法 | |
CN113514588B (zh) | 注射用双半胱乙酯有关物质的高效液相色谱分析方法 | |
CN109765316B (zh) | 一种从药物中检测右乙拉西坦的方法 | |
CN114264765B (zh) | 一种利用hplc测定格列美脲中间体中有关物质的分析方法 | |
CN114594168A (zh) | 一种吲哚布芬杂质的检测方法 | |
CN114624339A (zh) | 一种测定吲哚布芬杂质的分析方法 | |
CN110824059A (zh) | 一种非布司他中甲酰基杂质的检测方法 | |
CN110231416B (zh) | 一种利用hplc测定2-碘酰基苯甲酸有关物质的方法 | |
CN112611819B (zh) | 一种苯磷硫胺原料及其制剂中有关物质的测定方法 | |
CN113125626B (zh) | 一种从左乙拉西坦口服液中检测右旋异构体的hplc方法 | |
CN107091895B (zh) | 采用hplc分离测定利奥西呱原料药中有关物质的方法 | |
CN118067860A (zh) | 一种依帕司他片中有关物质的检测方法 | |
CN112394112B (zh) | 一种检测硫酸羟氯喹中羟氯喹氮氧化物杂质含量的方法 | |
CN116930363A (zh) | 恩扎卢胺sm1及相关杂质的分离、鉴别及定量检测方法 | |
CN118050452A (zh) | 一种盐酸利多卡因中4-甲基-3-戊烯-2酮含量的hplc检测方法 | |
CN118243804A (zh) | 盐酸莫西沙星片及注射液中光降解杂质的分离和检测方法 | |
CN113447592A (zh) | 一种甲硝唑凝胶中乙二胺四乙酸二钠的检测方法 | |
CN112394110A (zh) | 一种检测硫酸羟氯喹中羟氯喹硫酸酯杂质含量的方法 | |
CN117368383A (zh) | 一种硝酸硫康唑起始原料咪唑乙醇有关物质的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 317321 Da Zhan Xiang Tong Yuan Xi, Xianju County, Taizhou City, Zhejiang Province Applicant after: ZHEJIANG CHARIOTEER PHARMACEUTICAL Co.,Ltd. Address before: 317332 Da Zhan Xiang Tong Yuan Xi, Xianju County, Taizhou City, Zhejiang Province Applicant before: ZHEJIANG CHARIOTEER PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for analyzing substances related to S-chlorophenylglycine methyl ester tartrate Granted publication date: 20231208 Pledgee: Zhejiang Xianju Rural Commercial Bank Co.,Ltd. Pledgor: ZHEJIANG CHARIOTEER PHARMACEUTICAL Co.,Ltd. Registration number: Y2024330000267 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |